Recent Material Events - Depomed, Inc (DEPO)

Filing Date	Description
2008-09-23	On September 22, 2008, Depomed, Inc. (the “Company”) released a letter from its President and CEO, Carl A. Pelzel, related to the Company’s recent business activities. The letter is attached hereto as Exhibit 99.1. ...
2008-07-22	On July 21, 2008, Depomed, Inc. (“Depomed”) entered into a promotion agreement (the “Promotion Agreement”) with Santarus, Inc. (“Santarus”) grantin g Santarus exclusive rights to promote Depomed’s Glumetza® (met ...
2008-07-01	On June 27, 2008, Depomed, Inc. (the “Company”) entered into a Loan and Security Agreement (the “Loan Agreement”) with General Electric Capital Corporation, as agent (“GECC”, or the “Agent”), and Oxford Finance ...
2008-06-09	On June 9, 2008, Depomed, Inc. (the “ Company ”) released a letter from its President and CEO, Carl A. Pelzel, related to the Company’s recent business activities. The letter is attached hereto as Exhibit 99.1. ...
2008-04-25	On April 22, 2008, Depomed, Inc. (the “ Company ”) entered into amendments to its existing leases agreements with Menlo Business Park, LLC (“ Menlo ”) for the Company’s premises at 1330, 1360 and 1430 O’Brien Drive, Menl ...
2008-04-08	On April 4, 2008, Depomed, Inc. (the “Company”) entered into a Settlement and License Agreement (the “Settlement Agreement”) with Teva Pharmaceuticals USA, Inc. (collectively with its affiliates, “Teva”) related to the p ...
2008-02-22	On February 19, 2008, the Company and Carl A. Pelzel, the Company’s President and Chief Executive Officer, amended the employment offer letter, dated as of August 24, 2007, between Mr. Pelzel and the Company (the “Pelzel Offer Letter”) ...
2007-12-12	Effective December 10, 2007, the Board of Directors of Depomed, Inc. (the “Company”) appointed James A. Schoeneck as a director of the Company. Mr. Schoeneck was also appointed as a member of the Audit Committee of the Board of Directors. ...
2007-10-18	On October 12, 2007, John W. Shell, Ph.D., 82, resigned as a member of the Board of Directors (the “Board”) of Depomed, Inc. (the “Company”). Dr. Shell is the founder of the Company and served as its Chairman of the Board from its ...
2007-10-11	On October 10, 2007, John F. Hamilton, the Vice President, Finance and Chief Financial Officer of Depomed, Inc. (the “ Company ”), retired from the Company, effective October 12, 2007. ...